| Groin tissue necrosis requiring skin graft following parenteral abuse of buprenorphine tablets. | |
| | |
MedLine Citation:
|
PMID: 15385230 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
In May 2002 Buprenorphine (Subutex) was listed on the Australian Pharmaceutical Benefits Schedule for treatment in opioid dependence. In addition to broadening treatment options, buprenorphine has the advantage of an improved safety profile. The risk of overdose is lessened but other risks remain due to diversion. French experience reports widespread deviation of buprenorphine sublingual tablets to intravenous injection. We report a case of attempted parenteral administration of buprenorphine tablets. Stringent protocols for dispensing are appropriate. |
| | |
Authors:
|
G F X Feeney; P Fairweather |
Publication Detail:
|
Type: Case Reports; Journal Article |
Journal Detail:
|
Title: Drug and alcohol review Volume: 22 ISSN: 0959-5236 ISO Abbreviation: Drug Alcohol Rev Publication Date: 2003 Sep |
Date Detail:
|
Created Date: 2004-09-23 Completed Date: 2005-01-11 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 9015440 Medline TA: Drug Alcohol Rev Country: England |
Other Details:
|
Languages: eng Pagination: 359-61 Citation Subset: IM |
Affiliation:
|
Alcohol and Drug Assessment Unit, Princess Alexandra Hospital, Brisbane, Queensland, Australia. GeraldFeeney@health.qld.gov.au |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Adult Analgesics, Opioid / administration & dosage, adverse effects* Buprenorphine / administration & dosage, adverse effects* Female Groin / pathology*, surgery* Humans Necrosis / chemically induced* Skin Transplantation / methods* Substance Abuse, Intravenous / complications* |
| Chemical | |
Reg. No./Substance:
|
0/Analgesics, Opioid; 52485-79-7/Buprenorphine |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Update: comparison of drug use in Australia and the United States as seen in the 2001 National House...
Next Document: What can the Swiss and Dutch trials tell us about the potential risks associated with heroin prescri...